Paracchi Pierluigi 4

What Happened

• Pierluigi Paracchi, CEO of Genenta Science S.p.A. (GNTA), was granted 100,000 derivative securities (reported as a 100,000-share award) on March 30, 2026. The reported acquisition price is $0.00 (derivative), indicating a grant/award rather than a market purchase or sale.

Key Details

• Transaction date: 2026-03-30; Report filed with the SEC: 2026-05-05.
• Reported price/amount: 100,000 shares @ $0.00 (derivative); total cash paid reported as $0.
• Vesting: Footnote F1—these stock options/awards vest in equal monthly installments over three years beginning March 30, 2026.
• Shares owned after transaction: Not specified in the provided filing.
• Timeliness: The Form 4 was filed on May 5, 2026 for a March 30 transaction, which is later than the typical 2-business-day filing requirement (the filing appears late).

Context

• This filing documents an award/grant (an acquisition of derivative securities), not a market purchase or sale — it does not indicate immediate selling or buying pressure. The grant vests monthly over three years; there is no indication in the filing of a cashless exercise or immediate disposition.